A detailed history of Pineridge Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pineridge Advisors LLC holds 1,194 shares of LLY stock, worth $950,758. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,194
Previous 1,194 -0.0%
Holding current value
$950,758
Previous $1.08 Billion 2.17%
% of portfolio
0.4%
Previous 0.37%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$724.87 - $909.04 $724 - $909
-1 Reduced 0.08%
1,194 $1.08 Billion
Q1 2024

May 16, 2024

SELL
$592.2 - $792.28 $84,092 - $112,503
-142 Reduced 10.62%
1,195 $930 Million
Q4 2023

Mar 01, 2024

BUY
$525.19 - $619.13 $702,179 - $827,776
1,337 New
1,337 $779 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pineridge Advisors LLC Portfolio

Follow Pineridge Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pineridge Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pineridge Advisors LLC with notifications on news.